ProShare Advisors
SLDB icon

ProShare Advisors’s Solid Biosciences SLDB Stock Holding History

ProShare Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Buy
13,530
+1,497
+12% +$11.3K ﹤0.01% 1733
2026
Q1 		$86.6K Sell
12,033
-2,185
-15% -$14K ﹤0.01% 1722
2025
Q4 		$80.2K Buy
14,218
+1,362
+11% +$7.38K ﹤0.01% 1902
2025
Q3 		$79.3K Sell
12,856
-3,575
-22% -$20.9K ﹤0.01% 1872
2025
Q2 		$80K Buy
+16,431
New +$58.1K ﹤0.01% 1913
2022
Q2 		– Sell
-1,506
Closed -$27K – 2087
2022
Q1 		$27K Sell
1,506
-398
-21% -$7.02K ﹤0.01% 2162
2021
Q4 		$49K Buy
+1,904
New +$58.2K ﹤0.01% 2288
2021
Q3 		– Sell
-1,031
Closed -$57K – 2233
2021
Q2 		$57K Buy
+1,031
New +$68.1K ﹤0.01% 2352
2020
Q4 		– Sell
-697
Closed -$21K – 2100
2020
Q3 		$21K Sell
697
-18
-3% -$689 ﹤0.01% 1627
2020
Q2 		$31K Buy
+715
New +$29.7K ﹤0.01% 1644
2020
Q1 		– Sell
-841
Closed -$56K – 1526
2019
Q4 		$56K Sell
841
-138
-14% -$15.2K ﹤0.01% 1742
2019
Q3 		$152K Buy
979
+204
+26% +$23.1K ﹤0.01% 1487
2019
Q2 		$67K Sell
775
-116
-13% -$12.7K ﹤0.01% 1560
2019
Q1 		$123K Buy
891
+5
+0.6% +$1.25K ﹤0.01% 1551
2018
Q4 		$356K Buy
+886
New +$417K ﹤0.01% 1069

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ProShare Advisors's SLDB Position: Q2 2026 in Review

ProShare Advisors increased its Solid Biosciences (SLDB) stake by 12% in Q2 2026, buying an estimated $11.3K and bringing the position to 13,530 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #1733.

ProShare Advisors first reported a position in SLDB in Q4 2018 and has held it in 15 quarters since. The position peaked at $356K in Q4 2018. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • ProShare Advisors held 13,530 shares of Solid Biosciences worth $135K as of Q2 2026.
  • ProShare Advisors bought 1,497 Solid Biosciences shares in Q2 2026, an estimated $11.3K.
  • Solid Biosciences made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1733 holding.
  • ProShare Advisors first reported a position in Solid Biosciences in Q4 2018 and has held it in 15 quarters since.
  • ProShare Advisors's Solid Biosciences position peaked at $356K in Q4 2018.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.